open access

Vol 11, No 1 (2014)
Review paper
Get Citation

Second generation antipsychotics long-acting injections in the psychiatrist’s associations field

Sławomir Murawiec
Psychiatria 2014;11(1):23-28.

open access

Vol 11, No 1 (2014)
Prace poglądowe - nadesłane

Abstract

Any new medication or new treatment option must appear in psychiatrist’s mind before its implementation in clinical practice. That means it must appear also in the context of associations and experiences that have been achieved previously. This context in the case of second generation antipsychotics long acting injections is constituted in some degree by association with depot neuroleptics and the image of patients with chronic course of schizophrenia, with deficit symptoms and poor treatment adherence. It can be cause of confrontation in psychiatrist’s mind two set of images, one connected with this kind of patients and second of patients in firsts years of treatment and even patients with first episode psychosis. The latter group is recognized as suitable for treatment with new injectable antipsychotics. This field of associations can also include assumptions that patients will not accept long acting injections and large proportion of patients are never offered this treatment and associations of injection with the disease of particular strength and poor prognosis. Those can be reassured by the medication features as well as official rules and restriction in their use in clinical practice. The countertransference not-prescribing may require some conscious effort from the psychiatrist to become aware of one/s own associations connected with depot/long acting injections.

Abstract

Any new medication or new treatment option must appear in psychiatrist’s mind before its implementation in clinical practice. That means it must appear also in the context of associations and experiences that have been achieved previously. This context in the case of second generation antipsychotics long acting injections is constituted in some degree by association with depot neuroleptics and the image of patients with chronic course of schizophrenia, with deficit symptoms and poor treatment adherence. It can be cause of confrontation in psychiatrist’s mind two set of images, one connected with this kind of patients and second of patients in firsts years of treatment and even patients with first episode psychosis. The latter group is recognized as suitable for treatment with new injectable antipsychotics. This field of associations can also include assumptions that patients will not accept long acting injections and large proportion of patients are never offered this treatment and associations of injection with the disease of particular strength and poor prognosis. Those can be reassured by the medication features as well as official rules and restriction in their use in clinical practice. The countertransference not-prescribing may require some conscious effort from the psychiatrist to become aware of one/s own associations connected with depot/long acting injections.

Get Citation

Keywords

schizophrenia, long acting injectable antipsychotics, associations, countertransference

About this article
Title

Second generation antipsychotics long-acting injections in the psychiatrist’s associations field

Journal

Psychiatria (Psychiatry)

Issue

Vol 11, No 1 (2014)

Article type

Review paper

Pages

23-28

Bibliographic record

Psychiatria 2014;11(1):23-28.

Keywords

schizophrenia
long acting injectable antipsychotics
associations
countertransference

Authors

Sławomir Murawiec

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl